Cargando…

CHA(2)DS(2)-VASc score predicts exercise intolerance in young and middle-aged male patients with asymptomatic atrial fibrillation

Exercise intolerance among the clinical symptoms in patients with atrial fibrillation (AF) has usually been masked by their adjusted life style. We sought to assess the role of CHA(2)DS(2)-VASc score to predict exercise intolerance in asymptomatic AF patients, and further examine whether the relatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Jeong-Eun, Lee, Young Soo, Choi, Eue-Keun, Cha, Myung-Jin, Kim, Tae-Hoon, Park, Jin-Kyu, Lee, Jung-Myung, Kang, Ki-Woon, Shim, Jaemin, Uhm, Jae-Sun, Kim, Jun, Kim, Changsoo, Kim, Jin-Bae, Park, Hyung Wook, Joung, Boyoung, Park, Junbeom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303333/ https://www.ncbi.nlm.nih.gov/pubmed/30575764 http://dx.doi.org/10.1038/s41598-018-36185-7

Ejemplares similares

Stroke and Systemic Thromboembolism according to CHA(2)DS(2)-VASc Score in Contemporary Korean Patients with Atrial Fibrillation
por: Lee, Kyung Bae, et al.
Publicado: (2022)

CHA(2)DS(2)-VASc Score in the Prediction of Ischemic Stroke in Patients after Radiofrequency Catheter Ablation of Typical Atrial Flutter
por: Jin, Moo-Nyun, et al.
Publicado: (2018)

A Prospective Survey of Atrial Fibrillation Management for Real-world Guideline Adherence: COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF) Registry
por: Kim, Hyeongsoo, et al.
Publicado: (2017)

A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF)
por: Kim, Hyeongsoo, et al.
Publicado: (2020)

Comparative occurrence of ischemic stroke with the rhythm versus rate control strategy in a national prospective cohort of atrial fibrillation
por: Kim, Jae Guk, et al.
Publicado: (2021)

Comparison of Rhythm and Rate Control Strategies for Stroke Occurrence in a Prospective Cohort of Atrial Fibrillation Patients
por: Choi, Yu Jeong, et al.
Publicado: (2018)

Current Anticoagulant Usage Patterns and Determinants in Korean Patients with Nonvalvular Atrial Fibrillation
por: Ha, Hyun Su, et al.
Publicado: (2020)

Clinical Implications of Heart Rate Control in Heart Failure With Atrial Fibrillation: Multi-Center Prospective Observation Registry (CODE-AF Registry)
por: Song, Shinjeong, et al.
Publicado: (2022)

Label Adherence for Non-Vitamin K Antagonist Oral Anticoagulants in a Prospective Cohort of Asian Patients with Atrial Fibrillation
por: Lee, So-Ryoung, et al.
Publicado: (2019)

Clinical impact of left atrial enlargement in Korean patients with atrial fibrillation
por: Cho, Min Soo, et al.
Publicado: (2021)

Gender-related Differences in Management of Nonvalvular Atrial Fibrillation in an Asian Population
por: Lee, Jung Myung, et al.
Publicado: (2018)

Impact of carotid atherosclerosis in CHA(2)DS(2)-VASc-based risk score on predicting ischemic stroke in patients with atrial fibrillation
por: Cho, Dong-Hyuk, et al.
Publicado: (2021)

Predictors of stroke or systemic embolism in patients with non‐valvular atrial fibrillation with CHA(2)DS(2)‐VASc score of 0
por: Choi, Hyohun, et al.
Publicado: (2023)

Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA(2)DS(2)-VASc Score 0–1: A Korean Multi-Center Cohort
por: Jung, Moonki, et al.
Publicado: (2022)

Association of Gender With Clinical Outcomes in a Contemporary Cohort of Patients With Atrial Fibrillation Receiving Oral Anticoagulants
por: Kim, Minjeong, et al.
Publicado: (2022)

Stroke and systemic embolism in patients with atrial fibrillation and heart failure according to heart failure type
por: Uhm, Jae‐Sun, et al.
Publicado: (2021)

CHA(2)DS(2)-Vasc score and CHA(2)DS(2)-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents
por: Zhao, Sheng Gang, et al.
Publicado: (2019)

CHA(2)DS(2)-VASc: time to settle the score?
por: Kaplan, Rachel M., et al.
Publicado: (2022)

CHA2DS2-VASc score in acute ischemic stroke with atrial fibrillation: results from the Clinical Research Collaboration for Stroke in Korea
por: Lee, Hak-Loh, et al.
Publicado: (2021)

The difference of burden of ectopic beats in different types of atrial fibrillation and the effect of atrial fibrillation type on stroke risk in a prospective cohort of patients with atrial fibrillation (CODE-AF registry)
por: Cho, Seunghoon, et al.
Publicado: (2020)

Predictors of stroke or systemic embolism in patients with non-valvular atrial fibrillation with CHA2DS2-VASc score of 0
por: Park, Y, et al.
Publicado: (2023)

Rhythm Control and Cardiovascular or Cerebrovascular Outcomes in Patients with Atrial Fibrillation: A Study of the CODE-AF Registry
por: Chung, Ho-Gi, et al.
Publicado: (2023)

CHA(2)DS(2)-VASc and R(2)-CHA(2)DS(2)-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction
por: Węgiel, Michał, et al.
Publicado: (2018)

Clinical Outcomes of Rhythm Control Strategies for Asymptomatic Atrial Fibrillation According to the Quality‐of‐Life Score: The CODE‐AF (Comparison Study of Drugs for Symptom Control and Complication Prevention of Atrial Fibrillation) Registry
por: Kim, Ju Youn, et al.
Publicado: (2022)

CHA2DS2-VASc score and modified CHA2DS2-VASc score can predict mortality and intensive care unit hospitalization in COVID-19 patients
por: Gunduz, Ramazan, et al.
Publicado: (2021)

Oral Anticoagulation Therapy in Atrial Fibrillation Patients with Advanced Chronic Kidney Disease: CODE-AF Registry
por: Park, Hanjin, et al.
Publicado: (2023)

CHADS(2), CHA(2)DS(2)-VASc, ATRIA, and Essen stroke risk scores in stroke with atrial fibrillation: A nationwide multicenter registry study
por: Yu, Inwu, et al.
Publicado: (2021)

Heart failure: a weak link in CHA(2)DS(2)‐VASc
por: Friberg, Leif, et al.
Publicado: (2018)

CHA(2)DS(2)-VASc Score in Cardio-Oncology: Sharpening the Rules
por: López-Fernández, Teresa
Publicado: (2023)

2018 Korean Guideline of Atrial Fibrillation Management
por: Joung, Boyoung, et al.
Publicado: (2018)

Predicting stroke and death in patients with heart failure using CHA(2)DS(2)-VASc score in Asia
por: Son, Mi Kyoung, et al.
Publicado: (2019)

CHA(2)DS(2)-VASc score, cerebral small vessel disease, and frailty in older patients with atrial fibrillation
por: Choi, Jung-Yeon, et al.
Publicado: (2020)

Predictive value of CHA(2)DS(2)-VASc and CHA(2)DS(2)-VASc-HS scores for failed reperfusion after thrombolytic therapy in patients with ST-segment elevation myocardial infarction
por: Kilic, Salih, et al.
Publicado: (2019)

Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA(2)DS(2)VASC score: CCHA(2)DS(2)VASC score
por: Bungo, Brandon, et al.
Publicado: (2022)

Cheating the CHA(2)DS(2)-VASc Score: Thromboembolism in Apical Hypertrophic Cardiomyopathy
por: Weir, Robin A. P., et al.
Publicado: (2014)

Correlation between CHA(2)DS(2)-VASc Score and Glaucoma Treatment and Prognosis
por: Pikkel, Yoav Y., et al.
Publicado: (2018)

Beyond CHA(2)DS(2)-VASc in atrial fibrillation: the atrium and the risk of stroke
por: Boccanelli, Alessandro
Publicado: (2020)

Escore CHA2DS2-VASc: O Que Mais Podemos Predizer?
por: Maia, Adnaldo da Silveira
Publicado: (2023)

Association between CHADS(2), CHA(2)DS(2)-VASc, ATRIA, and Essen Stroke Risk Scores and Unsuccessful Recanalization after Endovascular Thrombectomy in Acute Ischemic Stroke Patients
por: Kim, Hyung Jun, et al.
Publicado: (2022)

Association between CHADS(2), CHA(2)DS(2)-VASc, ATRIA, and Essen Stroke Risk Scores and Functional Outcomes in Acute Ischemic Stroke Patients Who Received Endovascular Thrombectomy
por: Kim, Hyung Jun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oi26lq5i9qjunuo5q2ihct4jc9